Dandekar Atul sold MAZE
July 29, 2026 · Form 4 insider transaction
Dandekar Atul sold 400 shares of Maze Therapeutics, Inc. at $27.89 per share, a transaction worth $11.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
400
Price
$27.89
Total value
$11.2K
InsiderDandekar Atul
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 29, 2026
Filing dateJuly 31, 2026
Shares owned after26,250
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.81 to $27.96 per share, inclusive.